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In the previous issue of *Critical Care*, Kushimoto and colleagues \[[@B1]\] reported on the clinical usefulness of transpulmonary thermodilution-derived extravascular lung water (EVLW) and the pulmonary vascular permeability index (PVPI) in the diagnosis of acute respiratory distress syndrome (ARDS). In an observational multi-institutional study, 266 mechanically ventilated patients with hypoxemic respiratory failure and bilateral infiltration on chest radiography were retrospectively allocated by three experts into three pathophysiological diagnostic categories: ARDS (including acute lung injury, or ALI), cardiogenic edema, and pleural effusion with atelectasis. As a first step in identifying true ARDS, a threshold value of EVLW of greater than 10 mL/kg (of predicted body weight) was used to exclude patients who had no pulmonary edema at all (the \'atelectasis and pleural effusion\' group). As a second step, the PVPI, which is the ratio of the EVLW to the pulmonary blood volume (PBV), was used to separate patients with true ARDS from those with cardiogenic edema, achieving a very high specificity in the overall diagnosis or exclusion of ARDS \[[@B1]\].

The concept of the PVPI is based on the fact that although EVLW may be elevated in both permeability and cardiogenic edema, the latter will also be characterized by increased preload and, as a result, a lower PVPI ratio \[[@B2],[@B3]\]. The PVPI was originally described in an experimental study as the ratio of the EVLW to the intrathoracic blood volume (ITBV) and was found to be significantly higher in permeability compared with hydrostatic pulmonary edema \[[@B4]\]. In a more recent clinical study, PVPI values were significantly higher in ALI/ARDS compared with hydrostatic pulmonary edema, and a PVPI value of at least 3 allowed the diagnosis of ALI/ARDS with high sensitivity and specificity \[[@B5]\]. This PVPI value is similar to the one found in the study by Kushimoto and colleagues \[[@B1]\] in a larger group of patients.

However, the study by Kushimoto and colleagues \[[@B1]\] does have a number of limitations. The most disturbing one is that 14 patients, who were judged by the attending experts to have respiratory failure secondary to sepsis-induced increased pulmonary vascular permeability, were excluded from the study because \'their EVLW was less than 10 mL/kg due to hypovolemia\' \[[@B1]\]. This somewhat unclear exclusion is seemingly unjustified and, as the authors themselves readily admit, may have biased the results of the study. The authors claim that the experts were blinded to the PVPI but not to the EVLW and the ITBV. However, since the PBV is simply one fifth of the ITBV \[[@B2],[@B3]\] and since the EVLW/ITBV ratio itself was originally used to calculate PVPI \[[@B4]\], one cannot exclude the possibility that the experts may have had some idea of the PVPI value during the exclusion and allocation processes. Other limitations of this study include the inclusion of mechanically ventilated patients only, the small size of the non-ARDS groups, the unclear pathophysiology of the atelectasis and pleural effusion group, and the absence of a calculated predictive validity of EVLW and PVPI regarding mortality.

Despite its limitations, this study \[[@B1]\] presents an important addition to the mounting body of recent evidence showing that EVLW improves the diagnostic accuracy of lung injury and that it is a good predictor of mortality in ALI/ARDS \[[@B6]-[@B9]\]. Moreover, EVLW can predict progression to ALI more than 2 days before patients at increased risk for development of ALI meet American-European Consensus Conference (AECC) criteria, providing an early opportunity to initiate lung-protective ventilation and negative fluid balance \[[@B9]\]. The findings of these and other studies have already led to the suggestion that EVLW (\>10 mL/kg) should be included in the definition of ARDS \[[@B9]-[@B11]\].

The study of Kushimoto and colleagues \[[@B1]\] seems very relevant to the recent (\'Berlin\') definition of ARDS \[[@B12],[@B13]\], which was aimed at overcoming the limitations of the 1994 AECC definition \[[@B10],[@B12]-[@B16]\]. The most important aspects of the new \'Berlin\' criteria include the introduction of three categories of ARDS (mild, moderate, severe), abandoning the term \'acute lung injury\' and removing the \'wedge pressure\' criterion \[[@B12]-[@B14]\]. Although these changes add a modicum of evidence and some simplification to the AECC definition, its concepts and components, including the reliance on the arterial partial pressure of oxygen/fraction of inspired oxygen (PaO~2~/FiO~2~) ratio as the major tool for identifying and stratifying patients with ARDS, remain practically unchanged. As a result, none of the key criteria of the new definition does directly reflect its conceptual model, namely that \'ARDS is a type of acute diffuse, inflammatory lung injury, leading to increased pulmonary vascular permeability, increased lung weight, and loss of aerated lung tissue\' \[[@B12]\]. Therefore, it is no wonder that neither the AECC nor the Berlin definition was found to be a particularly good predictor of death, with the Berlin definition offering only marginal improvement \[[@B12],[@B14]\].

The Berlin task force did indeed consider a number of additional measures to improve specificity and face validity for the increased pulmonary vascular permeability, including EVLW \[[@B12]\]. The panel concluded that although EVLW has improved face validity and higher values are associated with mortality, it is infeasible to mandate since (a) its technology is costly, invasive, and not widely available; (b) it has significant methodological limitations; and (c) it does not distinguish hydrostatic from inflammatory pulmonary edema \[[@B13]\]. This last reservation, at least, has now been refuted by Kushimoto and colleagues \[[@B1]\] and by others \[[@B5]\]. Previously, the AECC had used the pulmonary artery catheter (PAC) in the diagnosis of ARDS, even though it was (still is!) also invasive, costly, and not widely available and certainly had significant methodological limitations. Compared with the PAC, transpulmonary thermodilution is less invasive but provides better parameters for the diagnosis and management of ARDS. The technology has also become more available since it is not limited to one vendor anymore.

The expanded rationale of the Berlin definition of ARDS \[[@B13]\] concludes by saying that the direct measurement of pulmonary vascular permeability or EVLW will be an important advance over current methods of assessing the presence and origin of lung edema and could be incorporated into the future definition of ARDS. The study of Kushimoto and colleagues \[[@B1]\] provides another justification for taking this step.
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